Algert Global LLC Grows Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Algert Global LLC raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 123.9% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 32,083 shares of the medical instruments supplier’s stock after purchasing an additional 17,753 shares during the period. Algert Global LLC’s holdings in DENTSPLY SIRONA were worth $799,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Bank of Nova Scotia boosted its position in DENTSPLY SIRONA by 92.3% during the fourth quarter. Bank of Nova Scotia now owns 16,141 shares of the medical instruments supplier’s stock worth $574,000 after acquiring an additional 7,747 shares during the last quarter. Royal London Asset Management Ltd. grew its position in shares of DENTSPLY SIRONA by 8.3% during the fourth quarter. Royal London Asset Management Ltd. now owns 96,106 shares of the medical instruments supplier’s stock worth $3,420,000 after buying an additional 7,381 shares in the last quarter. Cibc World Markets Corp acquired a new position in DENTSPLY SIRONA during the 4th quarter worth $761,000. Epoch Investment Partners Inc. grew its stake in DENTSPLY SIRONA by 7.3% in the fourth quarter. Epoch Investment Partners Inc. now owns 31,472 shares of the medical instruments supplier’s stock worth $1,120,000 after purchasing an additional 2,150 shares in the last quarter. Finally, Generation Investment Management LLP grew its position in shares of DENTSPLY SIRONA by 43.4% in the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock worth $234,830,000 after acquiring an additional 1,998,012 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Trading Up 2.1 %

Shares of NASDAQ XRAY opened at $25.22 on Friday. The business has a 50 day simple moving average of $25.47 and a 200 day simple moving average of $27.34. DENTSPLY SIRONA Inc. has a 52 week low of $23.58 and a 52 week high of $37.60. The stock has a market cap of $5.24 billion, a price-to-earnings ratio of -57.32, a PEG ratio of 1.20 and a beta of 1.00. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.01). The company had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same quarter last year, the business earned $0.51 EPS. On average, research analysts predict that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.54%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Analyst Ratings Changes

A number of equities analysts have commented on XRAY shares. Evercore ISI decreased their target price on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. Barrington Research reaffirmed an “outperform” rating and set a $36.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Needham & Company LLC reaffirmed a “buy” rating and issued a $34.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Robert W. Baird decreased their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a report on Monday, July 22nd. Finally, Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research report on Thursday, July 18th. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $33.22.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.